Tagged: fulbright
9 results
Pauline Roteta
Pauline Roteta is the co-founder and CEO of Pasito, a New York based startup building AI agents for the insurance and employee benefits industry. A former Senior Investor and Portfolio Manager at BlackRock, Fulbright Scholar, CFA and CFP, she launched Pasito in 2021 to attack the roughly $200 billion Americans waste each year on poor benefits decisions. Pasito went through Y Combinator's Summer 2022 batch and in February 2026 raised a $21 million Series A led by Insight Partners, bringing total funding to about $24.4 million.
Maor Farid
Maor Farid is the co-founder and CEO of Leo AI, the first AI copilot purpose-built for mechanical engineers. A former Captain in Israel's Unit 8200 intelligence corps and the youngest-ever PhD graduate from the Technion at age 24, he went on to do postdoctoral research at MIT as a Fulbright fellow, studying how to predict catastrophic failures in complex physical systems. He founded Leo AI in 2023 to build what he calls 'the most boring, unsexy AI' - a tool trained on more than a million vetted engineering sources that handles documentation, part searches and calculations so engineers can focus on design. Leo AI raised $9.7M and is used by teams at Toyota, HP, Mobileye, Philips and Scania.
Yiorgos Nikoletakis
Yiorgos Nikoletakis is the co-founder and CEO of 100mentors, an Athens- and San Francisco-based edtech company that started as a platform connecting young people with mentors worldwide and has since pivoted into generative-AI skilling for organizations. A Fulbright scholar with degrees from AUEB, Ohio State, and Columbia, he describes his job as teaching people to ask better questions, use GenAI well, and keep humans in the loop. His personal motto: arguing like he's right, listening like he's wrong.
Catherine Sabatos-Peyton
Catherine Sabatos-Peyton is a cancer immunologist turned biotech CEO who runs Larkspur Biosciences, a Cambridge, Massachusetts company building small-molecule drugs that attack cancer's ability to hide from the immune system. As a Harvard PhD student she helped first describe TIM-3, now a major checkpoint protein; she later led discovery of the anti-TIM-3 antibody sabatolimab at CoStim and Novartis. In 2021 she stepped from the lab bench to the corner office, and now leads an all-female executive team whose lead drug, the PIP4K2C degrader LRK-4189, entered human trials in late 2025.
Felix Herranz
Felix González Herranz is the Co-Founder and CEO of FounderNest, an AI-powered market intelligence platform serving Fortune 500 companies with tools for innovation scouting, competitive analysis, and M&A research. A Fulbright Scholar and Stanford GSB Arjay Miller Scholar, Felix built FounderNest from a problem he lived firsthand - helping companies find signal in a sea of 54 million company profiles. Before FounderNest, he worked at the Inter-American Development Bank across 20+ countries, consulted at The World Bank, and co-founded JuntoSalimos during Spain's 2009 economic crisis to support Spanish-speaking entrepreneurs. His clients include L'Oréal, Roche, Telefónica, AstraZeneca, and Novo Nordisk.
Josh Tetrick
Josh Tetrick is the co-founder and CEO of Eat Just, Inc., the San Francisco-based food technology company behind JUST Egg (a mung bean-based egg substitute) and GOOD Meat (the world's first commercially sold cultivated chicken). Starting with $37,000 of personal capital in 2011, he has raised over $456 million to build a company that simultaneously cracked the plant-based egg market and won the world's first regulatory approval for lab-grown meat in Singapore in 2020. A former Fulbright Scholar, UN initiative leader, and Cornell-educated lawyer turned food disruptor, Tetrick has made it his life's work to prove that removing animals from the food system doesn't mean sacrificing flavor or scale.
Adam Joseph
Adam Joseph is the Founder and CEO of Clipbook, the AI system of record for communications and public affairs teams. A Harvard summa cum laude graduate and Fulbright Scholar, he bootstrapped Clipbook to $1M ARR before landing a $3.3M seed round co-led by Mark Cuban - won through a single cold email. Before building Clipbook, he served as Communications Director for Abdul El-Sayed's historic 2018 Michigan gubernatorial campaign and as a Strategy Consultant at BCG, where he led healthcare and government transformation work. Clipbook now monitors 1M+ media and policy sources for 200+ clients including Weber Shandwick and BCG.
Niko Bonatsos
Niko Bonatsos is a Greek-born, Stanford-educated venture capitalist who spent 15 years at General Catalyst building one of Silicon Valley's strongest seed-stage consumer investment track records - backing Snap, Discord, Mercor, ClassDojo, and Dubsmash before most people knew they existed. In January 2026 he left General Catalyst to co-found Verdict Capital with Michael Fertik, targeting a $300M fund focused on seed/Series A investing in consumer and AI, with a particular contrarian bet on consumer AI being underappreciated in an enterprise-saturated market.
Omri Amirav-Drory
Omri Amirav-Drory, Ph.D., is a General Partner at NFX leading NFX Bio, a pre-seed and seed venture fund focused on scientist-founders at the intersection of technology and biology. A former Fulbright Scholar and Stanford postdoc turned biotech entrepreneur, he co-founded Genome Compiler (acquired by Twist Bioscience), launched Tech.Bio, and now backs breakthrough life sciences companies while co-founding Renewal Bio - a longevity company building synthetic embryo-derived tissues to combat aging. His stated mission is ending involuntary death.